Dan R. Burns
Amministratore Delegato presso InfaCare Pharmaceutical Corp.
Profilo
Dan R.
Burns is currently the President, Chief Executive Officer & Director at InfaCare Pharmaceutical Corp.
He previously held positions as the Chief Executive Officer at ProScript, Inc. from 1998 to 1999, Chief Executive Officer at HealthTalk, Inc. from 2000 to 2002, and Vice President-Business Development at MannKind Corp.
He also served as the President & Chief Operating Officer at Trophix Pharmaceuticals, Inc. from 1997 to 1998.
Mr. Burns has a background in business and holds an undergraduate degree from McMaster University and Mohawk College.
Posizioni attive di Dan R. Burns
| Società | Posizione | Inizio |
|---|---|---|
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Amministratore Delegato | 01/04/2007 |
Precedenti posizioni note di Dan R. Burns
| Società | Posizione | Fine |
|---|---|---|
| MANNKIND CORPORATION | Corporate Officer/Principal | 16/02/2007 |
HealthTalk, Inc.
 HealthTalk, Inc. Internet Software/ServicesTechnology Services HealthTalk, Inc. provides online health information services. It offers services in the areas such as asthma, chronic lymphocytic leukemia, psoriasis, migraine, sclerosis, and rheumatoid arthritis. The company was founded by Greg Harris in 2007 and is headquartered in Seattle, WA. | Amministratore Delegato | 01/01/2002 |
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Amministratore Delegato | 01/01/1999 |
Trophix Pharmaceuticals, Inc.
 Trophix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of NPS Allelix Corp., Trophix Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in South Plainfield, NJ. The company was founded by Jeffrey F. McKelvy. Trophix Pharmaceuticals was acquired by Allelix Biopharmaceuticals, Inc. on July 30, 1997 for $27 million. | Presidente | 01/01/1998 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formazione di Dan R. Burns
| McMaster University | Undergraduate Degree |
| Mohawk College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| Aziende private | 4 |
|---|---|
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Health Technology |
Trophix Pharmaceuticals, Inc.
Trophix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of NPS Allelix Corp., Trophix Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in South Plainfield, NJ. The company was founded by Jeffrey F. McKelvy. Trophix Pharmaceuticals was acquired by Allelix Biopharmaceuticals, Inc. on July 30, 1997 for $27 million. | Health Technology |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Health Technology |
HealthTalk, Inc.
HealthTalk, Inc. Internet Software/ServicesTechnology Services HealthTalk, Inc. provides online health information services. It offers services in the areas such as asthma, chronic lymphocytic leukemia, psoriasis, migraine, sclerosis, and rheumatoid arthritis. The company was founded by Greg Harris in 2007 and is headquartered in Seattle, WA. | Technology Services |
- Borsa valori
- Insiders
- Dan R. Burns